AKT1 and lung cancer: TADC-derived AMPHIREGULIN induces STAT3 and AKT activation, which increases the expression of the EMT markers SNAIL and TWIST, indicating that the collaboration of STAT3 and AKT plays a crucial role in TADC-mediated chemoresistance in lung cancer [65].